149 related articles for article (PubMed ID: 38499632)
21. [Prognostic factors in supraglottic laryngeal cancer: a review of 74 cases].
Zapater E; Campos A; Fortea M; Armengot M; Basterra J
Acta Otorrinolaringol Esp; 2000 Mar; 51(2):120-8. PubMed ID: 10804113
[TBL] [Abstract][Full Text] [Related]
22. Deep learning model for predicting the survival of patients with primary gastrointestinal lymphoma based on the SEER database and a multicentre external validation cohort.
Wang F; Chen L; Liu L; Jia Y; Li W; Wang L; Zhi J; Liu W; Li W; Li Z
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12177-12189. PubMed ID: 37428248
[TBL] [Abstract][Full Text] [Related]
23. [Application value of machine learning algorithms for predicting recurrence after resection of early-stage hepatocellular carcinoma].
Ji GW; Wang K; Xia YX; Li XC; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):679-685. PubMed ID: 34192861
[No Abstract] [Full Text] [Related]
24. Prognostic value of age, subglottic, and anterior commissure involvement for early glottic carcinoma treated with CO
Carta F; Bandino F; Olla AM; Chuchueva N; Gerosa C; Puxeddu R
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1199-1210. PubMed ID: 29442166
[TBL] [Abstract][Full Text] [Related]
25. Deep learning models for predicting the survival of patients with chondrosarcoma based on a surveillance, epidemiology, and end results analysis.
Yan L; Gao N; Ai F; Zhao Y; Kang Y; Chen J; Weng Y
Front Oncol; 2022; 12():967758. PubMed ID: 36072795
[TBL] [Abstract][Full Text] [Related]
26. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
[TBL] [Abstract][Full Text] [Related]
27. Comparison of MRI radiomics-based machine learning survival models in predicting prognosis of glioblastoma multiforme.
Zhang D; Luan J; Liu B; Yang A; Lv K; Hu P; Han X; Yu H; Shmuel A; Ma G; Zhang C
Front Med (Lausanne); 2023; 10():1271687. PubMed ID: 38098850
[TBL] [Abstract][Full Text] [Related]
28. Importance of tumor volume in supraglottic and glottic laryngeal carcinoma.
van Bockel LW; Monninkhof EM; Pameijer FA; Terhaard CH
Strahlenther Onkol; 2013 Dec; 189(12):1009-14. PubMed ID: 24196282
[TBL] [Abstract][Full Text] [Related]
29. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
Peretti G; Piazza C; Penco S; Santori G; Del Bon F; Garofolo S; Paderno A; Guastini L; Nicolai P
Head Neck; 2016 Jul; 38(7):1107-12. PubMed ID: 26970262
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
31. [Clinical study of early laryngeal cancer].
Nagatani G; Mori T; Udaka T; Shiomori T; Ohbuchi T; Suzuki H
Nihon Jibiinkoka Gakkai Kaiho; 2007 Jun; 110(6):447-52. PubMed ID: 17633113
[TBL] [Abstract][Full Text] [Related]
32. [Pathologic tumor volume predicting survival outcomes of patients with local advanced glottic carcinoma].
Gong H; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Zhou J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Apr; 35(4):316-320. PubMed ID: 33794628
[No Abstract] [Full Text] [Related]
33. Radiomics of dual-energy computed tomography for predicting progression-free survival in patients with early glottic cancer.
Li W; Zhang H; Ren L; Zou Y; Tian F; Ji X; Li Q; Wang W; Ma G; Xia S
Future Oncol; 2022 May; 18(15):1873-1884. PubMed ID: 35293227
[No Abstract] [Full Text] [Related]
34. [Characteristics of cervical lymph node metastasis of cN0 laryngeal carcinoma].
Shen CX; Li YS; Wang ZH; Liu C; Lu T; Zeng Q; Wang XQ; Zhu J; Cao YD; Hu GH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 54(5):343-348. PubMed ID: 31137093
[No Abstract] [Full Text] [Related]
35. [Patterns and prognostic factors of cervical lymph node metastasis in supraglottic laryngeal carcinoma].
Li X; Di B; Shao Y; Shang Y; Cheng J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 18(12):707-10. PubMed ID: 15831037
[TBL] [Abstract][Full Text] [Related]
36. Postoperative Radiotherapy Omitting Level Ⅳ for Locally Advanced Supraglottic and Glottic Laryngeal Carcinoma.
Wu Y; Zhang L; Tang T; Li L; Li L; Yu H
Technol Cancer Res Treat; 2021; 20():1533033820985876. PubMed ID: 33517858
[TBL] [Abstract][Full Text] [Related]
37. Comparison of prognostic and treatment between T1a and T1b glottic cancer: a propensity score-matched SEER database analysis.
Fang L; Tuohuti A; Shi L; Chen X
Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3313-3322. PubMed ID: 37039896
[TBL] [Abstract][Full Text] [Related]
38. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
[TBL] [Abstract][Full Text] [Related]
39. Pathologic Tumor Size as a Predictor of the Survival Outcomes of Patients With Glottic Carcinoma.
Gong H; Zhou L; Wu H; Tao L; Zhang M; Chen X; Li X; Li C; Zhou J; Wang S
Otolaryngol Head Neck Surg; 2021 Feb; 164(2):353-358. PubMed ID: 32633609
[TBL] [Abstract][Full Text] [Related]
40. [Analyses of recurrences and nodal metastases of glottic carcinoma after operation].
Wang Q; Zhao W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Sep; 17(9):529-31. PubMed ID: 14658185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
